Nano-hydroxyapatite is being investigated as vital components of implants and dental and tissue engineering devices. It is found as a bone replacement due to its non-toxicity and cytocompatibility with dental tissues and bone. The reality that nanocrystalline hydroxyapatite can be made of porous granules and scaffolds. Additionally, it has a massive loading potential indicating its use as a transporter for drugs or a regulated drug release mechanism in pharmaceutical research. This review aims to present existing nano-hydroxyapatite research developments as a drug carrier employed in bone tissue disorders locally and deliver poorly soluble drugs with reduced bioavailability. We have discussed the nano-hydroxyapatite role in the delivery of drugs (i.e. anti-resorptive, anti-cancer, and antibiotics), proteins, genetic material, and radionuclides.
CITATION STYLE
Munir, M. U., Salman, S., Javed, I., Bukhari, S. N. A., Ahmad, N., Shad, N. A., & Aziz, F. (2021). Nano-hydroxyapatite as a delivery system: overview and advancements. Artificial Cells, Nanomedicine and Biotechnology. Taylor and Francis Ltd. https://doi.org/10.1080/21691401.2021.2016785
Mendeley helps you to discover research relevant for your work.